Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2009 | 03-2009 | 12-2008 | |
Operating Expenses | 3,286 | 3,761 | 0 |
Operating Income | -3,286 | -3,761 | N/A |
Interest Expense | 59 | 37 | 0 |
Other Income | 9 | 13 | 0 |
Pre-tax Income | -3,336 | -3,785 | 0 |
Net Income Continuous | -3,336 | -3,785 | N/A |
Net Income | $-3,336 | $-3,785 | $N/A |
EPS Basic Total Ops | -142.72 | -164.48 | N/A |
EPS Basic Continuous Ops | -142.72 | -164.69 | N/A |
EPS Diluted Total Ops | -142.72 | -164.48 | N/A |
EPS Diluted Continuous Ops | -142.72 | -164.69 | N/A |
EBITDA(a) | $-3,281 | $-3,756 | $N/A |